Nakamoto, Inc. (NAKA)
5.00
-0.79
(-13.64%)
USD |
NASDAQ |
Nov 13, 16:00
4.93
-0.07
(-1.40%)
After-Hours: 19:59
Nakamoto EPS Diluted (Quarterly) : 4.068 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.068 |
| June 30, 2026 | -6.650 |
| March 31, 2026 | -15.01 |
| December 31, 2025 | 2.913 |
| September 30, 2025 | -16.95 |
| June 30, 2025 | -14.20 |
| March 31, 2025 | -0.1723 |
| December 31, 2024 | -6.644 |
| September 30, 2024 | -0.1697 |
| June 30, 2024 | -0.2222 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.0475 |
| December 31, 2023 | -0.0544 |
| September 30, 2023 | -0.0863 |
| June 30, 2023 | -0.0999 |
| March 31, 2023 | -0.0303 |
| December 31, 2022 | -2.988 |
| September 30, 2022 | -0.3556 |
| June 30, 2022 | -0.0059 |
| March 31, 2022 | 0.0106 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Astrana Health, Inc. | 0.2595 |
| Agilon Health, Inc. | 1.974 |
| Starling Oncology, Inc. | -0.1269 |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | -0.7535 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 85.81M |
| Revenue (Quarterly) | -1.929M |
| Total Expenses (Quarterly) | -87.74M |
| Enterprise Value | 237.18M |
| Profit Margin (Quarterly) | -4.45K% |
| Earnings Yield | -293.5% |
| Normalized Earnings Yield | -123.00 |